Vident Advisory’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.19M | Sell |
14,579
-3,162
| -18% | -$909K | 0.05% | 316 |
|
|
2025
Q1 | $5.47M | Buy |
17,741
+5,520
| +45% | +$1.7M | 0.08% | 218 |
|
|
2024
Q4 | $4.31M | Buy |
12,221
+1,596
| +15% | +$563K | 0.08% | 233 |
|
|
2024
Q3 | $3.81M | Buy |
10,625
+3,724
| +54% | +$1.33M | 0.1% | 215 |
|
|
2024
Q2 | $2.2M | Buy |
6,901
+1,806
| +35% | +$575K | 0.06% | 335 |
|
|
2024
Q1 | $1.17M | Buy |
5,095
+573
| +13% | +$132K | 0.02% | 531 |
|
|
2023
Q4 | $994K | Buy |
4,522
+1,818
| +67% | +$400K | 0.03% | 560 |
|
|
2023
Q3 | $611K | Buy |
+2,704
| New | +$611K | 0.02% | 644 |
|